Therapeutic Potential of CUDC-907 (Fimepinostat) for Hepatocarcinoma Treatment Revealed by Tumor Spheroids-Based Drug Screening

Background: Cancer is the second leading cause of death globally. However, most of the new anti-cancer agents screened by traditional drug screening methods fail in the clinic because of lack of efficacy. Choosing an appropriate in vitro tumor model is crucial for preclinical drug screening. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Wei, Yang, Wanren, Xu, Jiecheng, Yan, Zhengming, Pan, Mingxin, Xu, Xiaoping, Zhou, Shuqin, Zhu, Yu, Lan, Jianqiang, Zeng, Min, Han, Xu, Li, Shao, Li, Yang, Liang, Kangyan, Gao, Yi, Peng, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585736/
https://www.ncbi.nlm.nih.gov/pubmed/34776939
http://dx.doi.org/10.3389/fphar.2021.658197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585736/
https://www.ncbi.nlm.nih.gov/pubmed/34776939
http://dx.doi.org/10.3389/fphar.2021.658197

Ejemplares similares